Ana Pedrero Gil/LinkedIn
Jul 24, 2026, 04:53
Ana Pedrero Gil: The Future of Blood-Derived Therapies
Ana Pedrero Gil, Anesthesiologist at Igualada University Hospital, shared a post on LinkedIn about a recent article by Kerstin Wendland et al., published in Transfusion Medicine and Hemotherapy, adding:
“Donated blood is no longer used only as standard transfusion components but is increasingly being developed into new types of therapies.
This review explains recent progress in turning plasma, red blood cells (RBCs), platelets, donor stem cells, and cord blood into more advanced medical products.”
Title: From Donation to Innovation: New Blood-Derived Products
Authors: Kerstin Wendland, Kathleen Selleng, Konstanze Aurich
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 24, 2026, 05:15Jade Morrissey: Grateful to Present My PhD Research in Immunothrombosis at ISTH 2026
-
Jul 24, 2026, 05:04Moustafa Abdou: Unmasking Pure Red Cell Aplasia
-
Jul 24, 2026, 04:50Marc Wittwer: How We’re Making Hemostasis Diagnostics Faster, Simpler, and More Ergonomic
-
Jul 24, 2026, 04:41Akshat Jain: Reassessing Cost-Effectiveness of Iron Deficiency Anemia Treatments
-
Jul 24, 2026, 04:36Mehari Gebreyohanns: The Official Event Page for ASOC 2026 Is Now Live
-
Jul 24, 2026, 03:57Balvinder Bobbie Saarsalu: Hemostatic Biomarkers in Acute Myeloid Leukemia
-
Jul 24, 2026, 03:49Fateme Babaha: Pleasure to Present A Novel FVIII Gene Therapy Enhancer at ISTH 2026
-
Jul 24, 2026, 03:44Manabu Inoue: Tenecteplase or Alteplase Before Thrombectomy by T-FLAVOR Trial
-
Jul 24, 2026, 03:36We Received The AHA Get With The Guidelines Stroke Gold Plus Quality Achievement Award – Lakeland Regional Health-Florida